| Literature DB >> 31610787 |
Robin Larsson1,2, Susanne Bernhardsson3,4, Lena Nordeman3,5.
Abstract
BACKGROUND: Subacromial impingement syndrome is a common problem in primary healthcare. It often include tendinopathy. While exercise therapy is effective for this condition, it is not clear which type of exercise is the most effective. Eccentric exercises has proven effective for treating similar tendinopathies in the lower extremities. The aim of this systematic review was therefore to investigate the effects of eccentric exercise on pain and function in patients with subacromial impingement syndrome compared with other exercise regimens or interventions. A secondary aim was to describe the included components of the various eccentric exercise regimens that have been studied.Entities:
Keywords: Eccentric exercise; Eccentric training; Subacromial impingement syndrome, shoulder impingement syndrome; Subacromial pain syndrome
Mesh:
Year: 2019 PMID: 31610787 PMCID: PMC6792214 DOI: 10.1186/s12891-019-2796-5
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Flow diagram of the selection process. Modified from Moher et al., 2009
Characteristics and risk of bias of included studies
| Author, year, country | Participants | Intervention (details in Table | Control | Outcome measures | Follow-up period | PEDro score for quality (details in 2) | Cochrane score for clinical relevance (details in Appendix 3) |
|---|---|---|---|---|---|---|---|
| Bateman et al. 2014, United Kingdom [ | Eccentric exercise; Intensity: pain reproduction | Resistance exercise (concentric phase only); Intensity matched experiment group | Pain: VAS; Function: Oxford Shoulder Score | 8 weeks (post-treatment) | 5/10 | 4/5 | |
| Blume et al. 2015, United States [ | Eccentric exercise; Intensity: 70–80% of 1RM | Resistance exercise (concentric phase only); Intensity matched experiment group | Pain: NPRS; Function: DASH | 8 weeks (post-treatment) | 8/10 | 5/5 | |
| Chaconas et al. 2017, United States [ | Eccentric exercise; Intensity: 65% of 1RM | Resistance exercise; Intensity lower than experiment group | Pain: NPRS; Function: WORC | 6 weeks (post-treatment) & 6 months (intermediate term follow-up) | 6/10 | 5/5 | |
| Dejaco et al. 2017, Netherlands [ | Eccentric exercise; Intensity: pain reproduction | Resistance exercise; Intensity matched experiment group | Pain: VAS; Function: Constant-Murley Score | 12 weeks (post-treatment) & 6 months (intermediate term follow-up) | 7/10 | 5/5 | |
| Hallgren et al. 2014, Sweden [ | Pain: VAS; Function: Constant-Murley Score | 1 year (long-term follow-up) | 7/10 | 5/5 | |||
| Holmgren et al. 2012, Sweden [ | Eccentric exercise; Intensity: pain reproduction; Corticosteroid injection | Mobility exercise; Intensity lower than experiment group; Corticosteroid injection | Pain: VAS; Function: Constant-Murley Score | 12 weeks (post-treatment) | 7/10 | 5/5 | |
| Maenhout et al. 2013, Belgium [ | Eccentric exercise; Intensity: pain reproduction | Resistance exercise; Intensity matched experiment group | Pain and function: SPADI | 12 weeks (post-treatment) | 6/10 | 5/5 | |
| Vallés-Carrascosa et al. 2018, Spain [ | Eccentric exercise, pain up to 40–50 mm on VAS | Eccentric exercise, pain free execution | Pain: VAS; Function: Constant-Murley Score | 4 weeks (post-treatment) | 7/10 | 5/5 | |
SIS Shoulder Impingement Syndrome, VAS Visual Analogue Scale, NPRS Numerical Pain Rating Scale, DASH Disabilities of the Arm, Shoulder and Hand questionnaire, WORC The Western Ontario Rotator Cuff index, SPADI Shoulder Pain and Disability Index
Summary of eccentric training regimens
| Study | Duration | Frequency | Intensity | Sets/reps | Equipment | Exercise(s) |
|---|---|---|---|---|---|---|
| Bateman et al. (2014) [ | 8 weeks | 2 times/day | Same intensity for all participants, increased for all after 4 weeks, pain during execution allowed but not specified | 3 × 15 | Elastic exercise band: yellow and red | Full can with elastic band, only eccentric phase |
| Blume et al. (2015) [ | 8 weeks | 2 times/week | Approx. 70–80% of 1RM, no increase of pain during execution | 3 × 12 | Dumbbells | Full can; sidelying ER; sidelying IR; supine protraction; sidelying horizontal abduction; sidelying abduction; prone shoulder extension; all with dumbbell, only eccentric phase + Pectoralis minor and posterior shoulder stretch, thoracic spine extension, pain-free AROM in flexion and abduction (accessory exercises done daily) |
| Chaconas et al. (2017) [ | 6 weeks | 1 time/day | Approx. 65% of 1RM (15–18 RM), no increase of pain during execution | 3 × 15 | TheraBand: green, blue, black, silver, gold | ER with elastic band, only eccentric phase + Scapular retraction with elastic band, cross body posterior shoulder stretch |
| Dejaco et al. (2017) [ | 12 weeks | 2 times/day | Pain reproduction, but not over 5 of 10 (NPRS) during execution | 3 × 8–15 | Duraband Servofit + dumbbell 1 kg (when needed) | ER with elastic band, only eccentric phase; empty can with/without dumbbell, only eccentric phase |
| Hallgren et al. (2014) [ | ||||||
| Holmgren et al. (2012) [ | 12 weeks | 2 times/day | Pain reproduction, but not over 5 of 10 (VAS/NPRS) during execution | 3 × 15 | Dumbbells + elastic exercise band | Full can with dumbbell, only eccentric phase; ER with elastic band, only eccentric phase + 3 scapular stabilization exercises; posterior shoulder stretch |
| Maenhout et al. (2013) [ | 12 weeks | 2 times/day | Pain reproduction, but not over 5 of 10 (VAS/NPRS) during execution | 3 × 15 | Dumbbells + TheraBand: different colors | Full can with dumbbell, only eccentric phase + ER/IR with elastic band, no increase of pain during execution (3 × 10, once daily) |
| Vallés-Carrascosa et al. (2018) [ | 4 weeks (painful eccentric exercise) | 5 times/week | Pain reproduction, but not over 40–50 mm VAS during execution | 3 × 10 | Dumbbells + elastic exercise band | Full can with dumbbell, only eccentric phase + ER/IR with elastic band; 2 scapular stabilization exercises; trapezius-stretch |
| 4 weeks (pain-free eccentric exercise) | 5 times/week | No pain during execution, VAS = 0 mm | 3 × 10 | Dumbbells + elastic exercise band | Full can with dumbbell, only eccentric phase + ER/IR with elastic band; 2 scapular stabilization exercises; trapezius-stretch | |
Full can/empty can = shoulder abduction in scapular plane (scaption) with a thumbs up/thumbs down position; ER/IR external/internal rotation with neutral shoulder and elbow flexed 90°, RM Repetition Maximum, VAS Visual Analogue Scale, NPRS Numerical Pain Rating Scale
Summary of findings for the comparison eccentric exercise versus control exercise for subacromial impingement syndrome
| Outcomes, time frame | Absolute effect estimates (95% CI) | № of participants (studies) | Certainty in effect estimates (GRADE) | Conclusion | |
|---|---|---|---|---|---|
| Control exercise | Eccentric exercise | ||||
Pain: post-treatment (6–12 weeks) Measured by VAS or NPRS, converted to VAS 0–100 mm (lower better) MID: 15 mm | Mean post-treatment pain ranged across control groups from 15.0 to 63.9 mm | Mean post-treatment pain in the experimental group was | 281 (6 studies) | Lowa, b | Eccentric exercise may provide a small but likely not important reduction in pain post-treatment compared with other types of exercise. |
Pain: intermediate to long-term (6–12 months) Measured by VAS or NPRS, converted to VAS 0–100 mm (lower better) MID: 15 mm | Mean intermediate/long-term pain ranged across control groups from 18.0 to 52.1 mm | Mean intermediate/long-term pain in the experimental group was | 167 (3 studies) | Lowa, b | Eccentric exercise may result in little or no important difference in pain compared with other types of exercise. |
Function: post-treatment (6–12 weeks) Multiple scales of various range | N/A | Standardised mean post-treatment function in the experimental group was | 281 (6 studies) | Very lowa, b, c | It is uncertain whether eccentric exercise improves function more than other types of exercise post-treatment follow-up. |
Function: intermediate to long-term (6–12 months) Multiple scales of various range | N/A | Standardised mean intermediate/long-term function in the experimental group was | 167 (3 studies) | Very lowa, b, c | It is uncertain whether eccentric exercise improves function more than other types of exercise at intermediate/long-term follow-up. |
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
GRADE Grading of Recommendations Assessment, Development and Evaluation, MID minimal important difference, VAS Visual Analogue Scale, NPRS Numerical Pain Rating Scale, N/A not applicable
aDowngraded one level due to serious risk of bias (mainly due to lack of blinding)
bDowngraded one level due to serious imprecision (high heterogeneity in magnitude and direction of effect across studies, wide CIs, small study sizes)
cDowngraded one level due to clear inconsistency of results
Fig. 2Forest plot of post-treatment effects on pain, sub-grouped by treatment length of six to eight weeks and treatment length of 12 weeks. Dashed vertical line denotes minimal important difference (VAS 15 mm). IV = inverse-variance, VAS = visual analogue scale
Fig. 3Forest plot of intermediate to long-term (6–12 months) effects on pain. Dashed vertical lines denote minimal important difference (VAS 15 mm). IV = inverse-variance, VAS = visual analogue scale
Fig. 4Forest plot of post-treatment effects on function, sub-grouped by treatment length of six to eight weeks and treatment length of 12 weeks. Because the scales used in Dejaco 2017 and Holmgren 2012 go in the opposite direction (i.e. higher is better) than the ones used in the other studies, the mean values were multiplied by − 1. As a rule of thumb, a standardised mean difference of 0.2 represents a small difference, 0.5 a moderate, and 0.8 a large difference. IV = inverse-variance
Fig. 5Forest plot of intermediate to long-term effects on function. Because the scales used in Dejaco 2017 and Hallgren 2014 go in the opposite direction (i.e. higher is better) than the one used in the other study, the mean values were multiplied by − 1. As a rule of thumb, a standardised mean difference of 0.2 represents a small difference, 0.5 a moderate, and 0.8 a large difference. IV = inverse-variance
| Search | Query | Items found |
|
| Search (((((“shoulder impingement” OR “subacromial impingement” OR “subacromial pain” OR “rotator cuff”[tiab])) OR subacromial impingement syndrome[mh]) OR rotator cuff[mh])) AND (“eccentric exercise” OR “eccentric exercises” OR “eccentric training” OR “eccentric strengthening” OR “eccentric strength training”[tiab]) |
|
|
| Search “eccentric exercise” OR “eccentric exercises” OR “eccentric training” OR “eccentric strengthening” OR “eccentric strength training”[tiab] |
|
|
| Search (((“shoulder impingement” OR “subacromial impingement” OR “subacromial pain” OR “rotator cuff”[tiab])) OR subacromial impingement syndrome[mh]) OR rotator cuff[mh] |
|
|
| Search rotator cuff[mh] |
|
|
| Search subacromial impingement syndrome[mh] |
|
|
| Search “shoulder impingement” OR “subacromial impingement” OR “subacromial pain” OR “rotator cuff”[tiab] |
|
|
|
|
|
| #1 | (“shoulder impingement” OR “subacromial impingement” OR “subacromial pain” OR “rotator cuff”):ti,ab,kw (Word variations have been searched) | 1425 |
| #2 | MeSH descriptor: [Subacromial impingement syndrome] explode all trees | 280 |
| #3 | MeSH descriptor: [Rotator Cuff] explode all trees | 318 |
| #4 | #1 OR #2 OR #3 | 1425 |
| #5 | (“eccentric exercise” OR “eccentric exercises” OR “eccentric training” OR “eccentric strengthening” OR “eccentric strength training”):ti,ab,kw (Word variations have been searched) | 694 |
| #6 | #4 AND #5 | 27 |
|
|
|
| Abstract and title: (shoulder impingement” OR “subacromial impingement” OR “subacromial pain” OR “rotator cuff) AND eccentric, Clinical trial | 4 |
PEDro scores for the included studies
| Study | Eligibility criteria and source | Random allocation | Concealed allocation | Groups similar at baseline | Participant blinding | Therapist blinding | Assessor blinding | < 15% dropouts | Intention- to-treat analysis | Between-group difference reported | Point estimates and variability reported | Total score (0 to 10) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bateman et al. (2014) [ | Yes | Yes | Yes | Yes | No | No | No | Yes | No | Yes | No | 5 |
| Blume et al. (2015) [ | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | 8 |
| Chaconas et al. (2017) [ | Yes | Yes | No | Yes | No | No | Yes | Yes | No | Yes | Yes | 6 |
| Dejaco et al. (2017) [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
| Hallgren et al. (2014) [ | Yes | Yes | Yes | Yes | No | No | Yes | Yes | No | Yes | Yes | 7 |
| Holmgren et al. (2012) [ | Yes | Yes | Yes | Yes | No | No | Yes | Yes | No | Yes | Yes | 7 |
| Maenhout et al. (2013) [ | Yes | Yes | Yes | No | No | No | No | Yes | Yes | Yes | Yes | 6 |
| Vallés-Carrascosa et al. (2018) [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
Cochrane scale for clinical relevance
| Study | Are the patients described in detail so that you can decide whether they are comparable to those that you see in your practice? | Are the interventions and treatment settings described well enough so that you can provide the same for your patients? | Were all clinically relevant outcomes measured and reported? | Is the size of the effect clinically important? | Are the likely treatment benefits worth the potential harms? | Total score (0 to 5) |
|---|---|---|---|---|---|---|
| Bateman et al. (2014) [ | Yes | Yes | Yes | No | Yes | 4 |
| Blume et al. (2015) [ | Yes | Yes | Yes | Yes | Yes | 5 |
| Chaconas et al. (2017) [ | Yes | Yes | Yes | Yes | Yes | 5 |
| Dejaco et al. (2017) [ | Yes | Yes | Yes | Yes | Yes | 5 |
| Hallgren et al. (2014) [ | Yes | Yes | Yes | Yes | Yes | 5 |
| Holmgren et al. (2012) [ | Yes | Yes | Yes | Yes | Yes | 5 |
| Maenhout et al. (2013) [ | Yes | Yes | Yes | Yes | Yes | 5 |
| Vallés-Carrascosa et al. (2018) [ | Yes | Yes | Yes | Yes | Yes | 5 |
Outcome table for pain
| Study | Number of participants | Withdrawals/dropouts | Intervention | Control | Comments |
|---|---|---|---|---|---|
| Bateman et al. (2014) [ | I: 4 C1: 3 (concentric group) C2:4 (no exercise) | I: 1 C1: 0 C2: 1 | VAS Baseline: 53.0 (SD 14.2) Post-treatment (8 weeks): 43.5 (SD 26.5) Δ −9.5 | VAS Baseline: 42.3 (SD 6.9) Post-treatment (8 weeks): 51.7 (SD 17.6) Δ 9.4 | Between-group difference reported for intervention and concentric exercise group (C1). Second control group (C2) not reported because no intervention was given. Visual analog scale, 0–100 mm, where 100 indicates worst possible pain. |
| |||||
| Blume et al. (2015) [ | I: 18 C: 20 | I: 0 C: 4 | NPRS Baseline: 2.0 (SD 1.8) Post-treatment (8 weeks): 1.0 (SD 1.3) Δ −1.0 | NPRS Baseline: 2.1 (SD 1.6) Post-treatment (8 weeks): 1.5 (SD 2.2) Δ −0.6 | Numerical Pain Rating Scale. Range 0–10, where 10 indicates worst pain. Data for 8 weeks were provided via e-mail. |
| |||||
| Chaconas et al. (2017) [ | I: 25 C: 21 | I: 0 C: 2 | NPRS Best Pain: Baseline: 1.64 (SD 1.71) Post-treatment (6 weeks): 1.00 (SD 1.47) Δ −0.64 At 6 months: 0.54 (SD 1.18) Δ −1.10 Average Pain: Baseline: 3.72 (SD 2.03) Post-treatment (6 weeks): 1.40 (SD 1.68) Δ −2.32 At 6 months: 1.04 (SD 1.62) Δ −2.68 Worst pain: Baseline: 7.00 (SD 1.78) Post-treatment (6 weeks): 3.88 (SD 2.40) Δ −3.12 At 6 months: 3.32 (SD 2.91) Δ −3.68 | NPRS Best Pain: Baseline: 1.22 (SD 1.28) Post-treatment (6 weeks): 1.13 (SD 1.25) Δ − 0.09 At 6 months: 1.00 (SD 1.30) Δ − 0.22 Average Pain: Baseline: 3.30 (SD 1.61) Post-treatment (6 weeks): 2.70 (SD 2.03) Δ − 0.60 At 6 months: 2.14 (SD 1.83) Δ − 1.16 Worst pain: Baseline: 7.00 (SD 2.09) Post-treatment (6 weeks): 6.39 (SD 2.55) Δ − 0.61 At 6 months: 5.21 (SD 2.19) Δ − 1.79 | |
| |||||
| Dejaco et al. (2017) [ | I: 20 C: 16 | I: 1 C: 1 | VAS Baseline: 39.0 (SD 18.5) Post-treatment (12 weeks): 9.4 (SD 13.5) Δ − 29.6 At 6 months: 19.1 (SD 24.5) Δ − 19.9 | VAS Baseline: 42.0 (SD 27.0) Post-treatment (12 weeks): 18.9 (SD 15.8) Δ − 23.1 At 6 months: 19.8 (SD 18.5) Δ − 22.3 | |
| |||||
| Hallgren et al. (2014) [ | I: 51 C: 46 | I: 1 C:1 | VAS Pain at rest: Baseline: 15 (SD 19) At 1 year: 2 (SD 6) Δ − 13 Pain during activity: Baseline: 61 (SD 22) At 1 year: 18 (SD 23) Δ −43 Pain at night: Baseline: 46 (SD 28) At 1 year: 12 (SD 19) Δ − 34 | VAS Pain at rest: Baseline: 20 (SD 21) At 1 year: 4 (SD 13) Δ − 16 Pain during activity: Baseline: 66 (SD 20) At 1 year: 18 (SD 21) Δ −48 Pain at night: Baseline: 40 (SD 30) At 1 year: 14 (SD 21) Δ − 26 | Long-term follow-up of the study by Holmgren et al. 2012. NB: 12 patients in the intervention group and 29 in the control group underwent surgery but were still included in 1-year follow-up. |
| |||||
| Holmgren et al. (2012) [ | I: 51 C: 46 | I: 0 C: 0 | VAS Pain at rest: Baseline: 15 (SD 19) Post-treatment (12 weeks): 10 (SD 14) Δ − 5 Pain during activity: Baseline: 61 (SD 22) Post-treatment (12 weeks): 25 (SD 26) Δ − 36 Pain at night: Baseline: 46 (SD 28) Post-treatment (12 weeks): 15 (SD 22) Δ − 31 | VAS Pain at rest: Baseline: 20 (SD 21) Post-treatment (12 weeks): 20 (SD 25) Δ 0 * Pain during activity: Baseline: 66 (SD 20) Post-treatment (12 weeks): 41 (SD 27) Δ − 25 Pain at night: Baseline: 40 (SD 30) Post-treatment (12 weeks): 27 (SD 27) Δ − 13 | * Holmgren reports an erroneous value for within group change for VAS at rest for the control group (− 5). |
| |||||
| Maenhout et al. (2013) [ | I: 31 C: 30 | I: 4 C: 5 | SPADI Pain subscale Baseline: 25.8 (SD 10.4) Post-treatment (12 weeks): 11.0 (SD 9.5) Δ − 14.8 | SPADI Pain subscale Baseline: 28.4 (SD 12.4) Post-treatment (12 weeks): 11.0 (SD 11.5) Δ − 17.4 | Pain was measured using the SPADI. Data were provided via e-mail so that we could extract data for the pain subscale. Scale ranges from 0 to 50, higher score indicates worse pain. |
| |||||
| Vallés-Carrascosa et al. (2018) [ | I: 11 C: 11 | I: 0 C: 0 | VAS Baseline: 37.0 (32.0; 79.0) Post-treatment (4 weeks): 12.0 (3.0; 30.0) Δ − 25.0 | VAS Baseline: 55.0 (48.0; 68.0) Post-treatment (4 weeks): 28.0 (18.0; 37.0) Δ − 27.0 | Median (1st; 3rd quartile) |
| |||||
RCT randomized controlled trial, VAS Visual Analogue Scale, NPRS Numerical Pain Rating Scale, SPADI Shoulder Pain and Disability Index, ns not significant, CI confidence interval
Outcome table for function
| Study | Number of participants | Withdrawals/dropouts | Intervention Eccentric exercise (painful eccentric exercise) | Control Other exercise types (non-painful eccentric exercise) | Comments |
|---|---|---|---|---|---|
| Bateman et al. (2014) [ | I: 4 C1: 4 (concentric group) C2:3 (no exercise) | I: 1 C1: 1 C2: 0 | Oxford Shoulder Score Baseline: 34.0 (SD 5.3) Post-treatment (8 weeks): 31.3 (SD 6.3) Δ − 2.7 | Oxford Shoulder Score Baseline: 24.0 (SD 3.7) Post-treatment (8 weeks): 24.3 (SD 4.2) Δ + 0.3 | Control group 2 (C2) excluded because no treatment was given. Function measured with the 12-item Oxford Shoulder Score. Range 12–60, where 12 indicates no pain and normal function and higher is worse. MID 6 points [ |
| |||||
| Blume et al. (2015) [ | I: 18 C: 20 | I: 0 C: 4 | DASH Baseline: 25.0 (SD 10.6) Post-treatment (8 weeks): 12.1 (SD 11.7) Δ − 12.9 | DASH Baseline: 21.2 (SD 6.5) Post-treatment (8 weeks): 9.3 (SD 7.1) Δ − 11.9 | Function measured with the 30-item DASH questionnaire. Range 0–150, higher is worse. MID = 10.5 points [ |
| |||||
| Chaconas et al. (2017) [ | I: 25 C: 21 | I: 0 C: 2 | WORC Baseline: 66.6 (SD 16.0) Post-treatment (6 weeks): 87.6 (SD 14.5) Δ + 21.0 At 6 months: 92.7 (SD 9.0) Δ + 26.1 | WORC Baseline: 65.4 (SD 14.1) Post-treatment (6 weeks): 70.6 (SD 16.8) Δ + 5.2 At 6 months: 77.2 (SD 15.9) Δ + 11.8 | Function measured with WORC. Total range 0–2100 (aggregate score of 6 total sub-domains), here reported as scores out of 100 i.e. a percentage of normal score, where higher is better. MID = 275 points [ |
| |||||
| Dejaco et al. (2017) [ | I: 20 C: 16 | I: 1 C: 1 | Constant-Murley Score Baseline: 72.5 (SD 17.7) Post-treatment (12 weeks): 87.3 (SD 16.2) Δ + 14.8 At 6 months: 86.9 (SD 16.8) Δ + 14.4 | Constant-Murley Score Baseline: 78.9 (SD 8.5) Post-treatment (12 weeks): 87.6 (SD 7.8) Δ + 8.7 At 6 months: 88.8 (SD 8.1) Δ + 9.9 | Function measured with Constant-Murley Score. Four subscales (pain, ADL, ROM, strength). Total range 0–100, where 100 indicates excellent shoulder function. MID = 17 points [ |
| |||||
| Hallgren et al. (2014) [ | I: 51 C: 46 | I: 1 C:1 | Constant-Murley Score Baseline: 48.5 (SD 15.0) 1-year follow up: 83.0 (SD 14.0) Δ + 34.5 | Constant-Murley Score Baseline: 43.5 (SD 15.0) 1-year follow up: 76.0 (SD 18.0) Δ + 32.5 | Long-term follow-up of the study by Holmgren et al. 2012. Baseline values from the Holmgren et al. paper. |
| |||||
| Holmgren et al. (2012) [ | I: 51 C: 46 | I: 0 C: 0 | Constant-Murley Score Baseline: 48.5 (SD 15.0) Post-treatment (12 weeks): 72.5 (SD 19.0) Δ + 24 | Constant-Murley Score Baseline: 43.5 (SD 15.0) Post-treatment (12 weeks): 52.5 (SD 23.0) Δ + 9 | |
| |||||
| Maenhout et al. (2013) [ | I: 31 C: 30 | I: 4 C: 5 | SPADI Baseline: 42.0 (SD 11.0) Post-treatment (12 weeks): 17.0 (SD 11.4) Δ −25.7 | SPADI Baseline: 44.3 (SD 11.5) Post-treatment (12 weeks): 14.5 (SD 11.7) Δ − 27.0 | Measured with SPADI. A 13-item scale (5 items on pain, 8 on disability). Range 0–130, higher is worse. Pain and disability subscales not reported separately. MID = 18 points [ |
| |||||
| Vallés-Carrascosa et al. (2018) [ | I: 11 C: 11 | I: 0 C: 0 | Constant-Murley Score Baseline: 35.0 (22.0; 47.0) Post-treatment (4 weeks): 59.0 (50.0; 68.0) Δ + 24.0 | Constant-Murley Score Baseline: 36.0 (22.0; 45.0) Post-treatment (4 weeks): 65.0 (55.0; 69.0) Δ + 29.0 | Median (1st;3rd quartile) |
| |||||
DASH Disabilities of the Arm, Shoulder and Hand questionnaire, WORC Western Ontario Rotator Cuff index, SPADI Shoulder Pain and Disability Index, MID minimal important differences, ns not significant